Net Cash Provided by (Used in) Operating Activities |
1.12B |
USD |
+31% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-404M |
USD |
+10% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-1.08B |
USD |
-60.9% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
100K |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
100K |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
30 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-368M |
USD |
-37.3% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.95B |
USD |
+16.2% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
32M |
USD |
0% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Gross |
1.02B |
USD |
-26.9% |
Q4 2024 |
FY 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
850M |
USD |
+2.41% |
Q2 2025 |
Q2 2025 |
Deferred Income Tax Expense (Benefit) |
-225M |
USD |
-219% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
35M |
USD |
+25% |
Q4 2024 |
FY 2024 |
Current Income Tax Expense (Benefit) |
201M |
USD |
|
Q1 2025 |
Q1 2025 |
Unrecognized Tax Benefits |
21M |
USD |
-12.5% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
985M |
USD |
-27.7% |
Q4 2024 |
FY 2024 |